BEIJING—Novartis AG expects growth in China to recover after business restructuring in the country slowed the Swiss drug giant's sales here last year, Chief Executive Joe Jimenez said.
The Basel-based pharmaceutical company plans this year to increase its sales force in China, with the aim of selling more drugs to local hospitals and health clinics, Mr. Jimenez said in an interview Monday. He declined to specify how many employees Novartis will add to the roughly 5,000 it has currently in China.
via online.wsj.com
No comments:
Post a Comment